Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQQ: 55.40 0.00%   SPY: 165.93 -0.74%

Archive

Merck Hikes Diabetes Exposure Via Acquisition (MRK, JNJ, DEPO, ARRY, MNKD, SPEX, BIOD, AMLN, GNBT, ALKS, LLY, ARNA)

Posted by Jason Smith at 11:39AM on December 2nd

Pharmaceutical giant Merck (MRK) agreed to purchase Beverly, Massachusetts-based insulin maker SmartCells for as much as $500 million, boosting the firm’s exposure the diabetes segment, which generated $2.58 billion in 2009 revenue. Miller Tabak portfolio manager Les Funtleyder told Bloomberg, “We…

Read more …

Sharp Rebound for MannKind, Generex (GNBT, MNKD, SPEX, AMLN, NVO, ARRY)

Posted by Jason Smith at 1:35PM on March 23rd

Shares of Valencia, California-based Mannkind Corp (MNKD) are rebounding sharply after two days of declines in a recent downtrend spurred by the FDA’s request for additional information related to the company’s Afrezza inhaled insulin. The stock remains off by -10% over…

Read more …